Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
dc.citation.epage | 840 | en_US |
dc.citation.issueNumber | 4 | en_US |
dc.citation.spage | 831 | en_US |
dc.citation.volumeNumber | 204 | en_US |
dc.contributor.author | Spisek, R. | en_US |
dc.contributor.author | Kukreja, A. | en_US |
dc.contributor.author | Chen, L. -C. | en_US |
dc.contributor.author | Matthews, P. | en_US |
dc.contributor.author | Mazumder, A. | en_US |
dc.contributor.author | Vesole, D. | en_US |
dc.contributor.author | Jagannath, S. | en_US |
dc.contributor.author | Zebroski, H. A. | en_US |
dc.contributor.author | Simpson, A. J. G. | en_US |
dc.contributor.author | Ritter, G. | en_US |
dc.contributor.author | Durie, B. | en_US |
dc.contributor.author | Crowley, J. | en_US |
dc.contributor.author | Shaughnessy, Jr. J.D. | en_US |
dc.contributor.author | Scanlan, M. J. | en_US |
dc.contributor.author | Gure, A. O. | en_US |
dc.contributor.author | Barlogie, B. | en_US |
dc.contributor.author | Dhodapkar, M. V. | en_US |
dc.date.accessioned | 2016-02-08T10:14:36Z | |
dc.date.available | 2016-02-08T10:14:36Z | |
dc.date.issued | 2007 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | Specific targets of cellular immunity in human premalignancy are largely unknown. Monoclonal gammopathy of undetermined significance (MGUS) represents a precursor lesion to myeloma (MM). We show that antigenic targets of spontaneous immunity in MGUS differ from MM. MGUS patients frequently mount a humoral and cellular immune response against SOX2, a gene critical for self-renewal in embryonal stem cells. Intranuclear expression of SOX2 marks the clonogenic CD138? compartment in MGUS. SOX2 expression is also detected in a proportion of CD138+ cells in MM patients. However, these patients lack anti-SOX2 immunity. Cellular immunity to SOX2 inhibits the clonogenic growth of MGUS cells in vitro. Detection of anti-SOX2 T cells predicts favorable clinical outcome in patients with asymptomatic plasmaproliferative disorders. Harnessing immunity to antigens expressed by tumor progenitor cells may be critical for prevention and therapy of human cancer. | en_US |
dc.description.provenance | Made available in DSpace on 2016-02-08T10:14:36Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2007 | en |
dc.identifier.doi | 10.1084/jem.20062387 | en_US |
dc.identifier.issn | 0022-1007 | |
dc.identifier.uri | http://hdl.handle.net/11693/23485 | |
dc.language.iso | English | en_US |
dc.publisher | Rockefeller University Press | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1084/jem.20062387 | en_US |
dc.source.title | Journal of Experimental Medicine | en_US |
dc.subject | Syndecan 1 | en_US |
dc.subject | Transcription factor Sox2 | en_US |
dc.subject | Adaptive immunity | en_US |
dc.subject | Article | en_US |
dc.subject | Cell growth | en_US |
dc.subject | Cellular immunity | en_US |
dc.subject | Controlled study | en_US |
dc.subject | Embryonic stem cell | en_US |
dc.subject | Human | en_US |
dc.subject | Human cell | en_US |
dc.subject | Human tissue | en_US |
dc.subject | Immune response | en_US |
dc.subject | Monoclonal immunoglobulinemia | en_US |
dc.subject | Myeloma | en_US |
dc.subject | Priority journal | en_US |
dc.subject | Protein expression | en_US |
dc.subject | Biological Markers | en_US |
dc.subject | Cell Proliferation | en_US |
dc.subject | Cells, cultured | en_US |
dc.subject | Disease progression | en_US |
dc.subject | Embryonic stem cells | en_US |
dc.subject | Health | en_US |
dc.subject | HMGB Proteins | en_US |
dc.subject | Humans | en_US |
dc.subject | Immunoglobulin G | en_US |
dc.subject | Multiple Myeloma | en_US |
dc.subject | Neoplasms | en_US |
dc.subject | Paraproteinemias | en_US |
dc.subject | T-Lymphocytes | en_US |
dc.subject | Transcription Factors | en_US |
dc.subject | Treatment Outcome | en_US |
dc.title | Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.pdf
- Size:
- 772.79 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version